Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schlienz

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Neurotoxicology and Teratology|July 6, 2024
Prenatal tobacco and tobacco-cannabis co-exposure: Relationship with attention and memory in middle childhoodShannon Shisler, Jin-Kyung Lee, Nicolas J Schlienz, et al.
Cannabis and Cannabinoid Research|May 17, 2021
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported HealthNicolas J Schlienz, Ryan Scalsky, Erin L Martin, et al.
Drug and Alcohol Dependence|April 17, 2020
Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabisNicolas J Schlienz, Tory R Spindle, Edward J Cone, et al.
Frontiers in Pharmacology|September 23, 2022
Online survey of medicinal cannabis users: Qualitative analysis of patient-level dataAlbert Garcia-Romeu, Joshua Elmore, Rhiannon E Mayhugh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2024
Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivorsMichelle Goulette, Nicolas J Schlienz, Amy A Case, et al.
Clinical Pharmacology and Therapeutics|December 2, 2011
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trialL W Hawk, R L Ashare, S F Lohnes, et al.
Journal of Analytical Toxicology|January 5, 2018
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy AdultsNicolas J Schlienz, Edward J Cone, Evan S Herrmann, et al.
Journal of Substance Use and Addiction Treatment|October 6, 2023
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorderDustin C Lee, Nicolas J Schlienz, Evan S Herrmann, et al.
Drug and Alcohol Dependence|November 19, 2016
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on vareniclineCourtney A Motschman, Julie C Gass, Jennifer M Wray, et al.
Journal of the National Cancer Institute. Monographs|August 7, 2024
Tobacco-cannabis co-use among cancer patients and survivors: findings from 2 US cancer centersDanielle M Smith, Jesse T Kaye, Kyle J Walters, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Neurotoxicology and Teratology|July 6, 2024
Prenatal tobacco and tobacco-cannabis co-exposure: Relationship with attention and memory in middle childhoodShannon Shisler, Jin-Kyung Lee, Nicolas J Schlienz, et al.
Cannabis and Cannabinoid Research|May 17, 2021
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported HealthNicolas J Schlienz, Ryan Scalsky, Erin L Martin, et al.
Drug and Alcohol Dependence|April 17, 2020
Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabisNicolas J Schlienz, Tory R Spindle, Edward J Cone, et al.
Frontiers in Pharmacology|September 23, 2022
Online survey of medicinal cannabis users: Qualitative analysis of patient-level dataAlbert Garcia-Romeu, Joshua Elmore, Rhiannon E Mayhugh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 5, 2024
Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivorsMichelle Goulette, Nicolas J Schlienz, Amy A Case, et al.
Clinical Pharmacology and Therapeutics|December 2, 2011
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trialL W Hawk, R L Ashare, S F Lohnes, et al.
Journal of Analytical Toxicology|January 5, 2018
Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy AdultsNicolas J Schlienz, Edward J Cone, Evan S Herrmann, et al.
Journal of Substance Use and Addiction Treatment|October 6, 2023
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorderDustin C Lee, Nicolas J Schlienz, Evan S Herrmann, et al.
Drug and Alcohol Dependence|November 19, 2016
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on vareniclineCourtney A Motschman, Julie C Gass, Jennifer M Wray, et al.
Journal of the National Cancer Institute. Monographs|August 7, 2024
Tobacco-cannabis co-use among cancer patients and survivors: findings from 2 US cancer centersDanielle M Smith, Jesse T Kaye, Kyle J Walters, et al.
Pageof 5